NO163954C - Analogifremgangsmaate for fremstilling av et terapeutisk aktivt amidinderivat. - Google Patents
Analogifremgangsmaate for fremstilling av et terapeutisk aktivt amidinderivat.Info
- Publication number
- NO163954C NO163954C NO86860865A NO860865A NO163954C NO 163954 C NO163954 C NO 163954C NO 86860865 A NO86860865 A NO 86860865A NO 860865 A NO860865 A NO 860865A NO 163954 C NO163954 C NO 163954C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- amidine derivative
- analogy procedure
- active amidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15504584A JPS6133173A (ja) | 1984-07-25 | 1984-07-25 | アミジン化合物 |
PCT/JP1985/000392 WO1986000893A1 (en) | 1984-07-25 | 1985-07-12 | Novel amidine compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO860865L NO860865L (no) | 1986-04-10 |
NO163954B NO163954B (no) | 1990-05-07 |
NO163954C true NO163954C (no) | 1990-08-15 |
Family
ID=15597463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO86860865A NO163954C (no) | 1984-07-25 | 1986-03-07 | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt amidinderivat. |
Country Status (19)
Country | Link |
---|---|
US (2) | US4777182A (xx) |
EP (1) | EP0190356B1 (xx) |
JP (1) | JPS6133173A (xx) |
KR (2) | KR870001087B1 (xx) |
AU (1) | AU567039B2 (xx) |
CA (1) | CA1254205A (xx) |
CS (1) | CS255891B2 (xx) |
DD (1) | DD235637A5 (xx) |
DE (1) | DE3582057D1 (xx) |
DK (1) | DK169069B1 (xx) |
ES (1) | ES8607218A1 (xx) |
FI (1) | FI78461C (xx) |
HU (1) | HU195769B (xx) |
MX (1) | MX160912A (xx) |
NO (1) | NO163954C (xx) |
PH (1) | PH20585A (xx) |
SU (1) | SU1456008A3 (xx) |
WO (1) | WO1986000893A1 (xx) |
ZA (1) | ZA855552B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3824236C1 (xx) * | 1988-07-16 | 1989-12-28 | Heidelberger Druckmaschinen Ag, 6900 Heidelberg, De | |
CA2032420A1 (en) * | 1989-12-22 | 1991-06-23 | Akira Okuyama | Guanidinobenzene derivatives |
US5238964A (en) * | 1990-04-05 | 1993-08-24 | Torii & Co., Ltd. | Agent for treatment of cerebrovascular contraction |
US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
ATE222583T1 (de) * | 1995-01-05 | 2002-09-15 | Torii Pharmaceutical Co Ltd | Derivate substituierter amidinonaphthylester |
US5932603A (en) * | 1995-01-05 | 1999-08-03 | Torii Pharmaceutical Co., Ltd. | Thrombolytic agents |
CA2320900C (en) | 1998-03-19 | 2009-10-27 | Bristol-Myers Squibb Company | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
WO2001077082A1 (fr) * | 1999-06-02 | 2001-10-18 | Torii Pharmaceutical Co., Ltd. | Derives de naphtalene |
WO2001094299A1 (fr) * | 2000-06-08 | 2001-12-13 | Shizuoka Coffein Co., Ltd. | Derives de benzene |
WO2006123675A1 (ja) * | 2005-05-17 | 2006-11-23 | Santen Pharmaceutical Co., Ltd. | アミジノ誘導体を有効成分として含む神経細胞の保護剤 |
EP1884236B1 (en) * | 2005-05-17 | 2011-03-02 | Santen Pharmaceutical Co., Ltd. | Angiogenesis inhibitor containing amine derivative as active ingredient |
WO2008058167A2 (en) * | 2006-11-07 | 2008-05-15 | Case Western Reserve University | Method for treating disorders associated with complement activation |
MX342120B (es) | 2010-07-09 | 2016-09-14 | William Owen Wilkison | Combinación de sistema de liberación prolongada/inmediata para productos farmacéuticos de vida media corta como el remogliflozin. |
JP6252991B2 (ja) * | 2012-07-04 | 2017-12-27 | 味の素株式会社 | ナファモスタットメシル酸塩の製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292429A (en) * | 1978-03-08 | 1981-09-29 | Ciba-Geigy Corporation | Imidazole urea and amido compounds |
JPS57179146A (en) * | 1981-04-28 | 1982-11-04 | Torii Yakuhin Kk | Amidine compound |
AU527371B2 (en) * | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
JPS60130561A (ja) * | 1983-12-16 | 1985-07-12 | Torii Yakuhin Kk | アミジン誘導体およびそれを含む強心剤 |
-
1984
- 1984-07-25 JP JP15504584A patent/JPS6133173A/ja active Granted
-
1985
- 1985-07-12 DE DE8585903394T patent/DE3582057D1/de not_active Expired - Fee Related
- 1985-07-12 HU HU853727A patent/HU195769B/hu not_active IP Right Cessation
- 1985-07-12 AU AU45492/85A patent/AU567039B2/en not_active Ceased
- 1985-07-12 EP EP85903394A patent/EP0190356B1/en not_active Expired - Lifetime
- 1985-07-12 CA CA000486773A patent/CA1254205A/en not_active Expired
- 1985-07-12 US US06/835,853 patent/US4777182A/en not_active Expired - Fee Related
- 1985-07-12 WO PCT/JP1985/000392 patent/WO1986000893A1/ja active IP Right Grant
- 1985-07-12 KR KR1019860700140A patent/KR870001087B1/ko active
- 1985-07-23 PH PH32559A patent/PH20585A/en unknown
- 1985-07-23 ES ES545482A patent/ES8607218A1/es not_active Expired
- 1985-07-23 DD DD85278877A patent/DD235637A5/de not_active IP Right Cessation
- 1985-07-23 ZA ZA855552A patent/ZA855552B/xx unknown
- 1985-07-24 CS CS855463A patent/CS255891B2/cs not_active IP Right Cessation
- 1985-07-24 MX MX206081A patent/MX160912A/es unknown
-
1986
- 1986-03-03 DK DK096286A patent/DK169069B1/da not_active IP Right Cessation
- 1986-03-04 FI FI860904A patent/FI78461C/fi not_active IP Right Cessation
- 1986-03-07 NO NO86860865A patent/NO163954C/no not_active IP Right Cessation
- 1986-03-10 KR KR1019860700140A patent/KR860700250A/ko not_active IP Right Cessation
- 1986-03-24 SU SU864027333A patent/SU1456008A3/ru active
-
1988
- 1988-07-11 US US07/217,405 patent/US4820730A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU4549285A (en) | 1986-02-25 |
JPS6133173A (ja) | 1986-02-17 |
ES545482A0 (es) | 1986-05-16 |
ZA855552B (en) | 1986-03-26 |
EP0190356B1 (en) | 1991-03-06 |
MX160912A (es) | 1990-06-14 |
JPH0461868B2 (xx) | 1992-10-02 |
FI78461C (fi) | 1989-08-10 |
CA1254205A (en) | 1989-05-16 |
WO1986000893A1 (en) | 1986-02-13 |
HUT42433A (en) | 1987-07-28 |
CS546385A2 (en) | 1987-07-16 |
CS255891B2 (en) | 1988-03-15 |
FI78461B (fi) | 1989-04-28 |
HU195769B (en) | 1988-07-28 |
NO860865L (no) | 1986-04-10 |
KR860700250A (ko) | 1986-08-01 |
ES8607218A1 (es) | 1986-05-16 |
AU567039B2 (en) | 1987-11-05 |
NO163954B (no) | 1990-05-07 |
FI860904A (fi) | 1986-03-04 |
EP0190356A1 (en) | 1986-08-13 |
US4777182A (en) | 1988-10-11 |
DK169069B1 (da) | 1994-08-08 |
DD235637A5 (de) | 1986-05-14 |
SU1456008A3 (ru) | 1989-01-30 |
DK96286D0 (da) | 1986-03-03 |
PH20585A (en) | 1987-02-20 |
KR870001087B1 (ko) | 1987-06-04 |
US4820730A (en) | 1989-04-11 |
DE3582057D1 (en) | 1991-04-11 |
DK96286A (da) | 1986-03-03 |
FI860904A0 (fi) | 1986-03-04 |
EP0190356A4 (en) | 1987-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO167572C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat. | |
NO164653C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt indol-derivat. | |
NO167142C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO164165C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater. | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
NO163954C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt amidinderivat. | |
NO167797C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan. | |
NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
NO165842C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. | |
NO159591C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat. | |
NO167570C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser. | |
NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
NO884176L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater. | |
NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
NO161177C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JANUARY 2001 |